Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide
Authors:
- 1 September 1985
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 28 (9) , 697-703
Abstract
HB 699 is a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. The mechanisms whereby it affects B-cell function have been studied in vitro with mouse islets. In the presence of 3 mmol/l glucose, HB 699 decreased 86Rb+ efflux and accelerated 45Ca2+ efflux from islet cells, depolarized the B-cell membrane and induced an electrical activity similar to that triggered by stimulatory concentrations of glucose, and increased insulin release. The changes in 45Ca2+ efflux and insulin release, but not the inhibition of 86Rb+ efflux, were abolished in the absence of Ca2+. In the presence of 10 mmol/l glucose, HB 699 increased 86Rb+ and 45Ca2+ efflux from the islets, caused a persistent depolarization of the B-cell membrane with continuous electrical activity, and markedly potentiated insulin release. All these changes were suppressed by omission of extracellular Ca2+. In the presence of 15 mmol/l glucose, diazoxide increased 86Rb+ efflux, hyperpolarized the B-cell membrane, suppressed electrical activity and inhibited insulin release. HB 699 reversed these effects of diazoxide. It is suggested that HB 699 decreases K+ permeability of the B-cell membrane, thereby causing a depolarization which leads to activation of voltage-dependent Ca channnels and Ca2+ influx, and eventually increases insulin release. A sulphonylurea group is thus not a prerequisite to trigger the sequence of events that is also thought to underlie the releasing effects of tolbutamide and glibenclamide.Keywords
This publication has 33 references indexed in Scilit:
- Sparteine increases insulin release by decreasing the K+ permeability of the B-cell membraneBiochemical Pharmacology, 1985
- Interaction of sulfonylurea with the pancreatic B-cellCellular and Molecular Life Sciences, 1984
- Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acidsJournal of Medicinal Chemistry, 1984
- Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cellsBiochemical Pharmacology, 1982
- Regulation of 86Rb outflow from pancreatic islets: the dual effect of nutrient secretagogues.The Journal of Physiology, 1981
- Effect of a new hypoglycaemic agent (HB 699) on the in vivo secretion of pancreatic hormones in the dogDiabetologia, 1981
- THE INFLUENCE OF AN ACYL-AMINO-ALCYL-BENZOIC ACID (HB 699) ON BIOSYNTHESIS AND SECRETION OF INSULIN IN ISOLATED RAT ISLETS OF LANGERHANS1981
- Tolbutamide stimulates Ca2+ influx in islet cells without reducing k+ conductanceDiabetologia, 1980
- Electrical characteristics of the beta-cells in pancreatic islets.1976
- Membrane potential of beta-cells in pancreatic isletsPflügers Archiv - European Journal of Physiology, 1974